selenocysteine and Carcinoma, Anaplastic

selenocysteine has been researched along with Carcinoma, Anaplastic in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gangapurkar, B; Jariwalla, RJ; Nakamura, D1
Zarbl, H; Zhang, X1
Kwon, TK; Lee, JT; Lee, TJ; Park, JW1

Other Studies

3 other study(ies) available for selenocysteine and Carcinoma, Anaplastic

ArticleYear
Differential sensitivity of various human tumour-derived cell types to apoptosis by organic derivatives of selenium.
    The British journal of nutrition, 2009, Volume: 101, Issue:2

    Topics: Adenocarcinoma; Adolescent; Adult; Animals; Anticarcinogenic Agents; Antineoplastic Agents; Apoptosis; Breast Neoplasms; Carcinoma; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Survival; Colonic Neoplasms; Cysteine; Epithelial Cells; Female; Humans; Liver Neoplasms; Male; Melanoma; Middle Aged; Neoplasms; Neuroectodermal Tumors, Primitive, Peripheral; Organoselenium Compounds; Selenium Compounds; Selenocysteine; Selenomethionine; Skin Neoplasms

2009
Chemopreventive doses of methylselenocysteine alter circadian rhythm in rat mammary tissue.
    Cancer prevention research (Philadelphia, Pa.), 2008, Volume: 1, Issue:2

    Topics: Animals; Breast Neoplasms; Carcinoma; Cell Cycle Proteins; Chemoprevention; Circadian Rhythm; Cysteine; Dose-Response Relationship, Drug; Female; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Mammary Glands, Animal; Methylnitrosourea; Nuclear Proteins; Oligonucleotide Array Sequence Analysis; Organoselenium Compounds; Period Circadian Proteins; Rats; Rats, Inbred F344; Selenium; Selenocysteine; Specific Pathogen-Free Organisms

2008
Se-methylselenocysteine sensitized TRAIL-mediated apoptosis via down-regulation of Bcl-2 expression.
    International journal of oncology, 2009, Volume: 34, Issue:5

    Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Carcinoma; Caspases; Cysteine; Down-Regulation; Drug Evaluation, Preclinical; Drug Synergism; Gene Expression Regulation, Neoplastic; Genes, bcl-2; Humans; Kidney Neoplasms; Organoselenium Compounds; Peptide Fragments; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Selenocysteine; TNF-Related Apoptosis-Inducing Ligand; Tumor Cells, Cultured

2009